RYTMONORM

This brand name is authorized in Croatia, Ecuador, Estonia, Germany, Hong Kong SAR China, Israel, Italy, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Spain, Turkey.

Active ingredients

The drug RYTMONORM contains one active pharmaceutical ingredient (API):

1	Propafenone UNII 33XCH0HOCD - PROPAFENONE HYDROCHLORIDE
	Propafenone is a class IC anti-arrhythmic agent. It has a stabilising action on myocardial membranes, reduces the fast inward current carried by sodium ions with a reduction in depolarisation rate and prolongs the impulse conduction time in the atrium, AV node and primarily, in the His-Purkinje system.
	Read more about Propafenone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
RYTMONORM Film-coated tablet	MPI, EU: SmPC	Medicines and Medical Devices Safety Authority (NZ)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C01BC03	Propafenone	C Cardiovascular system → C01 Cardiac therapy → C01B Antiarrhythmics, class I and III → C01BC Antiarrhythmics, class Ic
Discover more medicines within C01BC03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	02019096, 02019104, 02019133, 02019156
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	6229-MEE-0521, 6230-MEE-0521
EE	Ravimiamet	1020126, 1020137
ES	Centro de información online de medicamentos de la AEMPS	55538, 55541, 58275
HK	Department of Health Drug Office	14516
HR	Agencija za lijekove i medicinske proizvode	HR-H-271347714, HR-H-361093310, HR-H-869129052
IL	מִשְׂרַד הַבְּרִיאוּת	7781
IT	Agenzia del Farmaco	024862017, 024862029
LT	Valstybinė vaistų kontrolės tarnyba	1001726, 1003151, 1066051, 1068574, 1068575, 1073002, 1076135, 1088794, 1089258
MT	Medicines Authority	AA1187/03701
NL	Z-Index G-Standaard, PRK	26026, 26034
NZ	Medicines and Medical Devices Safety Authority	4784
PL	Rejestru Produktów Leczniczych	100056173, 100059208, 100059214, 100455681, 100460275, 100460282, 100463659
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68791001, W68792001
TR	İlaç ve Tıbbi Cihaz Kurumu	8699548091698, 8699548091704, 8699548751714